Clinical Trial Update: A Feasibility Study of the Surpass Aneurysm-Embolization System in Intracranial Arteries [Phase 1]

View source ↗

Summary

The Phase 1 feasibility trial of the Surpass Aneurysm-Embolization System for intracranial aneurysms was withdrawn from the study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Aneurysm

Drugs mentioned

• Surpass Aneurysm-Embolization System

Snippet

Sponsor: Surpass Medical Ltd. | Conditions: Aneurysm | Phase 1 | Status: WITHDRAWN